Termorex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Termorex

What is Termorex? An Overview

Termorex is an over-the-counter medicine widely used globally for its targeted effectiveness in managing mild-to-moderate pain and fever. It is often positioned to serve the needs of pediatric patients through accessible dosage forms.

Property Description
Active ingredient Paracetamol (Acetaminophen)
Form Oral liquids (syrup/drops) and solids (tablets)
Pharmacological class Analgesic and Antipyretic
Common use Temporary relief of pain and fever
Origin Synthetic compound

What Type of Medicine is Termorex?

Termorex is classified primarily as an Analgesic (pain reliever) and Antipyretic (fever reducer), which are considered its core pharmacological classes. The sole active ingredient is the widely known synthetic compound, Paracetamol (Acetaminophen). This classification means the medicine is specifically designed to manage the sensation of pain and elevated body temperature.

This medicine is characterized by its swift action. A distinctive feature of the Termorex product line is its focus on accessible dosage forms, often emphasizing flavored liquid syrup and drops to facilitate easier administration, particularly for children.


Understanding Core Composition and Forms

The composition of Termorex is centered on Paracetamol and is made available in different forms suitable for various target groups. It is typically found as oral tablets or an oral liquid syrup with an aqueous base. The primary route of administration is oral, ensuring the medicine is absorbed through the digestive tract. While often a single-ingredient product, it may also be found in combination with other agents, such as those used for cold or flu symptoms.

What is Termorex Used for (General Purpose)?

The general purpose of Termorex is to provide swift, temporary relief from two common symptoms: pain and fever. It offers effective relief from common discomforts like headaches, muscle aches, and general body pains. Crucially, the medicine helps to bring down high body temperature often associated with minor illnesses, with the overall goal of improving temporary comfort and well-being.

What side effects are possible with Termorex?

Possible Side Effects and Safety Information: Termorex

Official regulatory alerts from bodies including the World Health Organization (WHO) and national regulatory agencies identify a severe product quality risk specifically associated with certain batches of Termorex syrup.

Documented Safety Risk

Contamination and Acute Toxicity: The primary safety concern is the presence of toxic contaminants, specifically unacceptable amounts of ethylene glycol and/or diethylene glycol. These industrial solvents should not be present in human medicines and are highly poisonous when consumed, particularly by children.

  • Serious Adverse Reactions: Ingestion of the contaminated product has been linked to reports of severe illness and fatalities. The toxicity from the contaminants can lead to systemic damage.
  • System-Organ Classes Involved (Contamination-Related): Acute toxicity involves multiple vital systems, including the central nervous system (CNS), cardiopulmonary system, and the renal system, resulting in acute kidney injury (AKI), metabolic acidosis, and altered mental state.

Population-Specific Caution

Official alerts emphasize the risk to pediatric populations (children) consuming liquid dosage forms, where the potential for severe injury or death is significant even with small amounts of contamination.

Regulatory Status and Restrictions

  • Regulatory Basis: The safety information is based on public health warnings and medical product alerts issued by governmental and international health authorities.
  • Safety Restriction: Authorities have ordered the recall and removal of specific contaminated batches from the market, such as batch AUG22A06 of Termorex syrup, due to being classified as substandard and unsafe. Continued use of affected batches is explicitly discouraged.

The established safety profile of Termorex is defined by this critical quality issue, necessitating extreme caution regarding product source and batch authenticity.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory guidance requires that immediate medical attention must be sought in all cases of suspected Termorex (Paracetamol/Acetaminophen) overdose, regardless of whether symptoms are currently present. Contacting a Poison Centre or emergency services is the mandated first action.

Documented Overdose Manifestations

Overdose may initially present with nonspecific symptoms such as Nausea, Vomiting, Abdominal Pain, Pallor (pale appearance), and Malaise. However, the absence of symptoms does not rule out serious toxicity. Delayed and critical manifestations include signs of Acute Liver Failure (ALF), such as Jaundice, Encephalopathy, and laboratory findings of elevated serum transaminases and Coagulopathy (e.g., increased INR) [NIH].

Severe Outcomes and Emergency Management

The primary, life-threatening outcome documented in regulatory sources is delayed, severe Hepatotoxicity potentially leading to Acute Liver Failure and Death [FDA]. The risk of toxicity is increased in patients with risk factors like chronic alcohol consumption or pre-existing liver disease.

Treatment protocols are centered on rapid assessment and intervention. The antidote N-acetylcysteine (NAC) is documented as available and effective, and its timely administration is critical. Procedures such as gastrointestinal decontamination (e.g., activated charcoal) may be utilized in a medical setting. Continuous hospital monitoring and laboratory testing are required to assess toxicity progression.

Therapeutic Uses of Termorex

What Termorex Treats: Main Uses and Benefits


The therapeutic role of Termorex is associated with symptomatic relief for common symptoms related to physical discomfort and systemic imbalance. The medication is utilized across therapeutic domains where short-term symptom management is appropriate.

Termorex is commonly used for managing symptoms such as headaches, muscle aches, menstrual discomfort, and toothache, and is primarily relevant in situations involving discomfort that is generally mild-to-moderate. It is applied across therapeutic domains involving heightened physiological activity, relevant for easing high body temperature (fever) associated with acute or disruptive episodes. Termorex may assist with managing symptoms that create noticeable physiological strain, which contributes to easing the overall symptom load during periods of heightened symptoms.

General Therapeutic Domains

Termorex supports symptom clusters that may become intense or disruptive, such as the combination of body aches and fever common in minor illnesses. This is commonly used in contexts where additional symptomatic support is needed, and supports general well-being during symptomatic phases for pediatric patients and adults experiencing temporary discomfort following immunization events or seasonal infections.


Quick Fact: Symptom Focus

Symptom Focus: Pain and Fever Management

Eligibility and Restrictions for Use

Official Population Eligibility for Termorex

The eligibility for Termorex (Paracetamol) is classified by regulatory authorities based on absolute prohibitions and necessary caution for certain populations.

Contraindicated Populations The medicine is contraindicated and must not be used by individuals with known hypersensitivity to the active substance or in the presence of severe hepatic impairment or severe active liver disease. Use is also prohibited when concurrently taking any other product that contains paracetamol.

Conditional and Restricted Use Use requires caution and is restricted for patients with certain clinical conditions. This includes individuals with severe renal impairment, who may require formal regulatory-mandated dose adjustment due to diminished kidney function. Caution is also advised for patients with risk factors for liver toxicity, such as those with chronic excessive alcohol consumption or states associated with glutathione depletion (e.g., severe malnutrition).

Age and Life Stage Eligibility Termorex is generally permitted for adults and adolescents. For the pediatric population, use is established for children aged 2 months and over using appropriate formulations, though certain solid forms are typically not recommended for children under 10 years of age. Regulatory authorities confirm Termorex is permitted and is the first-choice analgesic for use in both pregnancy and lactation when clinically indicated.

What should I know about interactions with other medicines?

Termorex (Paracetamol) has several officially documented interaction patterns that are defined by regulatory authorities. The most critical restriction is the formal prohibition of co-administration with any other medicine containing Paracetamol or Acetaminophen, which is mandated to prevent accidental overdose and subsequent acute liver failure.

Pharmacokinetic and Metabolic Interactions

Certain medicines affect the way Termorex is eliminated from the body. Probenecid causes a regulatory-documented reduction in paracetamol clearance by inhibiting its conjugation pathway, which may necessitate a dose consideration. Co-administration with Liver Enzyme Inducers, such as antiepileptics like Carbamazepine or Phenytoin, may increase the hepatotoxic potential due to the accelerated formation of a toxic metabolite. Similarly, Isoniazid decreases Termorex clearance, and Termorex itself may reduce the bioavailability of Lamotrigine.

Absorption and Pharmacodynamic Constraints

Agents like Metoclopramide or Domperidone officially increase the rate of absorption, accelerating the onset of effect. Conversely, the absorption-reducing agent Cholestyramine must be separated by at least 1 hour from Termorex administration. For pharmacodynamic effects, prolonged regular use with Warfarin is officially noted to enhance the anticoagulant effect, requiring increased monitoring of INR values.

Drug-Substance and Population Notes

The risk of severe liver damage is officially heightened by concurrent Alcohol consumption, especially in chronic users; some regulatory documents recommend a lower maximum daily dose in such cases. Furthermore, co-administration with Flucloxacillin is associated with the risk of high anion gap metabolic acidosis in patients with specific risk factors, such as severe renal impairment or malnutrition.

Mechanism of Action

Central Modulation of the Body's Thermoregulatory Set Point

The mechanism of Termorex (Paracetamol) involves modulation of specific pathways primarily within the Central Nervous System (CNS). Temperature regulation is mediated by the inhibition of Prostaglandin mathbfE2 (mathbfPGE2) synthesis in the hypothalamic thermoregulatory center. This interference targets the peroxidase function of central Cyclooxygenase (COX) enzymes, an action that resets the body's elevated thermal set point and initiates heat dissipation to influence systemic temperature.

Analgesia via Cannabinoid and Vanilloid Pathway Activation

Pain signal modulation is achieved via the active metabolite, AM404, which functions as an activator on the Cannabinoid Receptor 1 (CB1) and the Transient Receptor Potential Vanilloid-1 (TRPV1) channel in the spinal cord and brain. By engaging these pathways, the drug influences the activity of the natural descending inhibitory pathways, leading to the modulation of nociceptive signaling. This inhibitory mechanism is fundamentally constrained by the high peroxide tone characteristic of acutely inflamed peripheral tissue, focusing the drug's action profile on central temperature and pain perception pathways.

Dosage and Administration Information

Termorex (Paracetamol/Acetaminophen) is utilized in clinical practice according to standardized parameters detailing administration route, dose limits, and frequency. The medicine is available for several delivery methods, including the common oral route (tablets, liquids) and specialized administration via rectal suppositories or intravenous (IV) infusion in hospital settings.

The administration schedule is structured around maintaining a defined therapeutic level without exceeding established limits. Standard adult doses typically range from 650 mg to 1,000 mg (1 g) per intake. The total intake from all administration routes and product forms, including combination medicines, must not exceed 4,000 mg (4 g) in a 24-hour period. Doses are administered as required, observing a minimum dosing interval of 4 hours between successive intakes. Termorex may be taken with or without food.

Dosing Parameter Official Guideline (Adult)
Standard Single Dose 650 mg to 1,000 mg
Maximum Daily Dose 4,000 mg (4 g) total
Minimum Interval 4 hours between doses

For specific populations, standardized adjustments are required. Pediatric use requires strict weight-based dosing (e.g., 10 to 15 mg/kg) rather than fixed adult doses. Additionally, patients with existing hepatic impairment require a lower maximum daily limit, sometimes reduced to 2,000 mg or 3,000 mg. When using liquid forms, a calibrated dosing device must be used for accurate measurement.

Recent Clinical Evidence

Research evidence / Overview of Studies for Termorex

Evidence for Use in Acute Pain Management

Research has explored Termorex in the context of temporary, short-term management of outcomes related to physical discomfort. The evidence base primarily consists of Randomized Controlled Trials (RCTs) and systematic reviews applied in studies examining patient-reported experiences related to symptom intensity. This research was studied for patient-reported outcomes describing perceived discomfort associated with specific acute conditions. Study populations included a wide range of individuals, from adults to children and infants.

Findings describe patterns observed in the studies over very short observation periods, often within 48 hours of administration. For acute, mild-to-moderate discomfort, research highlights changes measured during the study period, and research describes patterns observed related to changes in measured outcomes compared to inactive compounds. However, the reported outcomes were short-term, and comparative evidence is lacking against other standard therapies in certain contexts.


Evidence for Use as a Fever Reducer

Termorex was studied for managing elevated body temperature, which is an outcome related to systemic or functional imbalance. Clinical studies explored outcomes describing episodic or acute changes in body temperature, including the time to onset of the measured outcome and how long that change was maintained. Studies monitored changes in body temperature over defined time intervals. Research suggests that measured outcomes related to temperature may be linked to the dose used in the clinical trial setting.

Research is ongoing, and existing studies primarily provide context regarding the immediate or short-term antipyretic evaluation. While Termorex was evaluated in a wide range of ages, evidence is limited regarding the long-term patterns associated with repeated use.


Key Evidence Gaps and Areas of Uncertainty

A review of the evidence highlights several areas where certainty remains low. Data for certain groups remain insufficient, especially for older adults or populations with complex health conditions. Furthermore, long-term effects are not fully established, as follow-up durations were limited in many key studies.

Frequently Asked Questions (FAQ)

Common questions about Termorex (FAQ)


Q: How quickly can a person expect Termorex to start having an effect?

Official product information indicates that the concentration of the medicine in the blood, which relates to its peak activity, is generally observed within 30 to 60 minutes after taking an oral dose. This time frame is generally associated with the onset of the medicine’s full therapeutic effect.

Q: How long does the effect of Termorex typically last?

Official dosing guidelines are structured around observing a minimum of 4 to 6 hours between successive doses. This minimum time interval is generally supported by studies that examine the typical duration of relief achieved with a single dose.

Q: Is Termorex approved for use in children under 12?

Regulatory documents confirm that use is established and permitted for the pediatric population, starting from the age of 2 months and older. Official prescribing information emphasizes that use in this age group is based on the strict application of appropriate weight-based liquid formulations.

Q: Are there specific instructions for how to stop using Termorex after long-term use?

Official guidelines often recommend a maximum duration for short-term use, generally limiting use for pain relief to 10 days and fever reduction to 3 days. When used within these limits, official labeling states that the medicine can be stopped when no longer required and does not necessitate a gradual reduction (tapering).

Q: Why does Termorex have to be taken under specific use conditions?

Specific conditions for use are mandated by regulatory authorities to ensure the medicine provides the desired effect while prioritizing patient safety. These conditions, such as the minimum interval between doses and the maximum daily limit, are designed to prevent the documented risk of acute liver toxicity.

Q: Is Termorex the same type of medicine as [A common, similar OTC drug]?

Official regulatory labeling classifies Termorex (Paracetamol/Acetaminophen) as an analgesic and an antipyretic. This means the compound is officially defined as a pain reliever and a fever reducer, which helps clarify its type and purpose.

Q: What happens if I miss a scheduled time to use Termorex?

Official patient information advises that a missed dose may be taken when remembered. However, the regulatory guidance emphasizes that the minimum time interval specified between doses must still be strictly observed to prevent accidental excessive intake.

Q: Does Termorex have a known risk of causing dependence or addiction?

Official regulatory documents explicitly state that Termorex is classified as having no known risk of physical or psychological dependence or addiction when used according to approved instructions.

Q: Can Termorex affect sleep patterns?

When reviewing official adverse event lists, effects like insomnia or excessive sleepiness are not typically highlighted as common occurrences. This indicates that a noticeable impact on sleep patterns is not a frequently documented effect in regulatory sources.

Q: Is it common to feel a little dizzy when first starting Termorex?

Official documentation lists dizziness as a possible rare adverse reaction. This indicates that while it is a documented side effect, it is not considered a common event when a person starts using the medicine.

Q: What are the most frequently reported side effects in official documentation for Termorex?

The most frequently reported adverse effects in official regulatory texts are typically related to the digestive system, including nausea, vomiting, and abdominal pain. Official documents also provide detailed information on serious, but rare, reactions that may occur.

Q: Does taking Termorex impact the effectiveness of hormonal birth control?

Regulatory documents on drug interactions indicate that Termorex does not typically affect the therapeutic efficacy of standard hormonal birth control (oral contraceptives).

Q: Is Termorex suitable for use in people over the age of 65?

Official information generally notes that no specific dose adjustment is typically required for the geriatric population, which includes people over the age of 65. However, regulatory labeling indicates that patients with pre-existing severe liver or kidney conditions may require special dose consideration.

Q: What does the research say about the long-term use of Termorex?

Regulatory reviews state that the long-term effects are not fully established based on the available data. Studies often had limited follow-up durations, meaning evidence is strongest for the short-term use of the medicine.

Q: Is there a maximum time a person can generally continue using Termorex?

Official guidelines generally recommend limiting use for pain relief to 10 days and for fever reduction to 3 days in adults. These are the recommended maximum durations for self-medication, unless a health professional provides specific instructions for longer use.

Q: Can Termorex be used during or near the time of a surgical procedure?

Official labeling advises caution and dose consideration for certain conditions often associated with surgery, such as glutathione depletion (due to fasting or severe illness) or in post-operative patients. This information indicates that use in this context is recognized by regulators but must be monitored by a health professional.

Q: Are headaches a temporary or long-term side effect noted with Termorex?

Headaches are documented in official adverse event lists as an uncommon side effect. This means they are a possible occurrence, but they are not listed as a guaranteed temporary effect of the medicine.

Q: Are there different safety classifications for Termorex in different countries?

Regulatory bodies across the world classify medicines based on their local laws and requirements. This means that Termorex may have different official classifications, such as being designated as Prescription Only Medicine (POM) or Over The Counter (OTC), depending on the country.

Q: Is it possible for Termorex to interact with herbal supplements like St. John's Wort?

Official documents caution against interactions with other medicines and substances that are classified as liver enzyme inducers. Because some herbal supplements may possess this activity, the regulatory warnings for liver enzyme induction are relevant in this context.

Q: Does Termorex require any specific monitoring (e.g., blood tests) during typical use?

Official documents state that monitoring, such as blood tests or liver enzyme level checks, is not generally required during short-term use within the recommended limits. However, monitoring is specified as necessary in cases of prolonged use or for patients with pre-existing health conditions.

Q: What is the evidence regarding Termorex's use in pregnant individuals?

Regulatory texts confirm that Termorex is permitted for use during pregnancy when clinically needed. The official guidance emphasizes that if used, it should be at the lowest effective dose for the shortest possible time.

Q: Is it true that Termorex cannot be stopped suddenly?

Regulatory labeling confirms that Termorex can be stopped suddenly when no longer required for pain or fever relief. The medicine is not associated with effects that necessitate a gradual reduction (tapering) process.

Q: What should be done if Termorex does not seem to be working after a few weeks?

Official regulatory guidelines indicate that if pain or fever symptoms persist, worsen, or are still present after the maximum recommended duration (e.g., 10 days for pain), this is considered a documented reason for seeking evaluation from a health professional.

Q: Is there an official list of known interactions with prescription antidepressants and Termorex?

Official interaction lists contain warnings for specific medicines that affect the metabolism of Termorex, such as certain antiepileptics. However, official sources do not provide a complete, exhaustive, and general list of interactions for all prescription antidepressants.

Q: Can Termorex cause skin sensitivity or rash?

Official regulatory documents contain a formal warning about the rare but serious occurrence of severe skin reactions (such as SJS or TEN). This indicates that skin sensitivity is a documented risk associated with the medicine.

Q: Does the time of day matter when using Termorex?

Official dosing guidelines primarily emphasize adhering to the minimum time interval between doses and the maximum daily limit, rather than a specific time of day. Consistency with the dosing interval is the main factor.

Q: Are there known reports of Termorex affecting kidney function?

Regulatory documents list severe renal impairment (kidney disease) as a condition that requires caution and may necessitate a dose adjustment. Furthermore, official adverse event lists acknowledge the very rare occurrence of kidney issues as a documented adverse effect.

Q: Is it necessary to inform a dentist about using Termorex before a procedure?

Regulatory-based patient guidelines recommend informing all healthcare professionals, including dentists, of all medicines and supplements being taken. This is standard precautionary information before any medical or dental procedure.

Q: How do the benefits of Termorex compare to its documented risks?

Regulatory authorities confirm the medicine has a positive risk-benefit profile for its approved short-term uses. This positive assessment is based on strict observance of the established dosing guidelines and stated contraindications.

Q: Does Termorex have any known interactions with vaccines?

Official information often details the use of Termorex in the context of treating or preventing post-vaccination fever. However, regulatory documents typically do not detail a direct drug interaction between Termorex and the vaccine itself.

Q: Is it normal to have mild stomach upset when starting Termorex?

Official adverse event lists include gastrointestinal symptoms such as nausea, vomiting, and abdominal pain as documented occurrences. These documented effects are consistent with the experience of mild stomach upset when starting the medicine.

Q: Do studies suggest Termorex is more suited for a specific age group?

Official research confirms that Termorex is effective and has an established safety profile across a broad range of ages. However, regulatory documents specifically emphasize the critical need for weight-based dosing when used in the pediatric population.

Q: What are the implications for driving or operating machinery while using Termorex?

Official regulatory labeling explicitly states that Termorex does not affect or has negligible influence on a person’s ability to drive or operate machinery.

Q: Does Termorex interact with common cold or flu medications?

Regulatory documents issue a strict warning against co-administration with any other medicine containing Paracetamol (Acetaminophen). This is a critical point of caution since Paracetamol is a component in many common cold and flu relief products.

Q: What is the meaning of the [Letter/Number code] sometimes seen on the Termorex packaging?

Regulatory requirements mandate that all medicine packaging must display a batch or lot number and an expiry date. These codes are crucial for product traceability and for authorities to execute safety recalls if necessary.

Q: How do I know if the side effects I am experiencing are severe or minor?

Official patient information defines specific reactions, such as signs of allergic reaction, severe skin rash, or symptoms of liver failure, as serious adverse events. The identification of such documented events is noted as a reason for seeking immediate medical evaluation.

Q: What information is provided in the Patient Information Leaflet (PIL) for Termorex?

Regulatory standards dictate that the Patient Information Leaflet (PIL) must contain specific, mandated sections. This information includes details on what the medicine is used for, official warnings, instructions on how to use it, documented side effects, and guidance on how to store it.

Q: Can Termorex be crushed or split if it is a tablet formulation?

The ability to safely split a tablet is determined by its official pharmaceutical formulation. Regulatory guidance generally advises that only tablets that are officially scored (have a dividing line) are permitted to be broken.

How should Termorex be stored and disposed of?

Termorex is a brand name often associated with Paracetamol (Acetaminophen) formulations. The following storage and disposal instructions are based strictly on the official regulatory labeling for this type of medication.

Storage Domain Requirement Summary (Official Labeling)
Storage Temperature Store at controlled room temperature (e.g., 20 C to 25 C or 68 F to 77 F). Do not store above 30 C.
Protection Protect from moisture and excessive heat. The product must not be frozen or refrigerated, unless explicitly stated on the label.
Packaging & Safety Keep the container tightly closed and store the medicine in its original container. It is mandatory to keep all medicines out of the sight and reach of children.
Disposal Dispose of unused or expired product according to local regulatory requirements. Do not dispose of the medicine in wastewater or household trash.

The official storage profile requires Termorex to be stored at controlled room temperature and protected from excessive heat and moisture. The product must not be frozen. To maintain its stability and effectiveness, it must be stored in its original, tightly closed container. A critical safety mandate is to keep the medicine out of the sight and reach of children. Unused or expired medication must be disposed of according to local pharmaceutical waste regulations and should not be discarded into household waste or wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Termorex found in:

A-Z Index: